LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Synthetic Gene Networks Enable Rapid Virus Detection

By LabMedica International staff writers
Posted on 04 Nov 2014
Image: Schematic diagram of the Synthetic Gene Network for detecting viral RNA molecules (Photo courtesy of the Wyss Institute).
Image: Schematic diagram of the Synthetic Gene Network for detecting viral RNA molecules (Photo courtesy of the Wyss Institute).
An original method for using engineered gene circuits has been developed that allows investigators to safely activate the cell-free, paper-based system by simply adding water.

The low-cost, easy-to-use synthetic gene network platform that can control the activity of genes and recognize nucleic acids and small molecules could enable the rapid detection of different strains of deadly viruses such as Ebola.

Scientists at the Wyss Institute for Biological Inspired Engineering (Harvard University, Boston, MA, USA) developed a cell-free, paper-based system suitable for use outside specialized laboratories. To test the clinical relevance of their method, they developed sensors capable of detecting ribonucleic acid (RNA) molecules made from genes that allow bacteria to survive antibiotics, as well as RNA molecules encoding proteins from two different strains of the highly deadly Ebola virus. When freeze-dried onto paper, the sensors quickly detected the presence of these RNA molecules demonstrating the usefulness of the approach for diagnostic purposes.

The scientists created circuits with colorimetric outputs for detection by eye and fabricated a low-cost, electronic optical interface for field use. They tested to see whether the enzyme activity required for transcription and translation could be reconstituted from freeze-dried cell-free expression systems, which normally require storage at -80 °C. A new generation of riboregulators was tested in an in vitro demonstration of toehold switches and these robust biomolecular switches provide tight translational regulation over transcripts and exhibit excellent orthogonality.

James J. Collins, PhD, a professor and senior author of the study, “Our paper-based system could not only improve tools currently only available in the laboratory, but would be readily useful for the field, and also improve the development of new tools. Considering the projected cost, reaction time, ease of use, and no requirement for laboratory infrastructure, we envision paper-based synthetic gene networks significantly expanding the role of synthetic biology in the clinic, global health, and education.” The study was published on October 23, 2014, in the journal Cell.

Related Links:

Wyss Institute for Biological Inspired Engineering



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
8-Channel Pipette
SAPPHIRE 20–300 µL

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more